NanoTemper launches Spectral Shift Technology

By The Science Advisory Board staff writers

March 28, 2022 -- NanoTemper Technologies has launched Spectral Shift technology within their Dianthus instrument, which the company said is built to handle the most challenging affinity-based screenings in drug discovery.

The development will aid in affinity-based screenings and drug discovery, which will alleviate challenges like targeting proteolysis-targeting chimeras, intrinsically disordered proteins, or fragment libraries, the company said.

NanoTemper's Dianthus instrument includes breakthrough Spectral Shift technology to handle the most challenging affinity-based screenings in drug discovery. Image courtesy of NanoTemper.

Copyright © 2022 scienceboard.net
 


Email Address:

First Name:

Last Name:

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.